This was a descriptive cross sectional study which was conducted in Khartoum state, Sudan, in the ultrasound departments of different hospitals and clinics from third of January 2016 to twenty of August 2016. Varicoceles sclerotherapy can be employed to resolve the testicular venous insufficiency and mitigate the severity of the prostatic-related urological symptoms in middle-aged and elderly men, so varicoceles can be considered a confounding variable in the development of the prostatic-related lower urinary tract symptoms. Only 16.66% of cases needed further surgery, while the rest had sufficient symptomatic relief post sclerotherapy. Minimal self-limiting complications occurred with an overall rate of 38.9%. We observed a statistically insignificant improvement in the sexual satisfaction, prostatic volumes, post-void residual volumes, and PSA levels. The technical and clinical success rates reached 91.7% and 83.3%, respectively, with a statistically significant reduction in the IPSS and QoL scores. Venography showed reflux in all cannulated spermatic veins with subsequent sclerotherapy on the left side and bilaterally in 80.6% and 11.1% of the patients, respectively. A median international prostatic symptom score (IPSS) of 19 and a quality of life (QoL) score ranging (3–6) reflected the severity of the urinary symptoms. The patients complained of urinary symptoms and had prostatomegaly with varicoceles by sonography. Our single-arm interventional study included 36 patients with an age range of 40–80 years. The purpose of our study is to detect the effect of testicular venous sclerotherapy on the prostatic enlargement and the related urinary symptoms. Subsequently, prostatic congestion and androgen-dependent prostatic hyperplasia occur resulting in lower urinary symptoms development. The valvular destruction of the spermatic veins (varicoceles development) incurs a testicular-prostatic hydrostatic pressure gradient, which conveys free undiluted testosterone to the prostate via a testicular-prostatic backdoor passage. New pathophysiologic mechanisms of BPH development are currently under study to modulate its management. Statistically a significant difference in mean was seen among different age groups (pīenign prostatic hyperplasia (BPH) is inescapable with aging and can cause lower urinary tract symptoms, worsening the quality of life. while maximum mean value was seen in the 70-79 years of age. Minimum post void residual urine was seen in age group of 40-49 years (3.42 -+2.23ml). Results: It was seen that in the lower age groups, the prostate size was smaller, while in the higher age group it was higher (p>0.001). Transabdominal suprapubic ultrasound was done to measure post void residual urine. Prostate volume was calculated with the help of inbuilt software, by measuring 3 dimensions of prostate in transverse and longitudinal sections. Transrectal ultrasonography was performed using 7.5 MHZ transrectal probe. Materials and Methods: The present study was performed in 100 patients. Estimation of accurate intravesical, residual urine has significant importance and serves as an index of adequacy of bladder emptying.Īims and Objectives: The study aimed to measure the post void residual urine volume with age in Prostate outflow obstruction and compare the prostate volume and post void residual urine with age by ultrasonography. Predictive risk factors associated with chance of developing urinary retention includes age, symptoms, urinary flow rate and prostate size. Due to the central hypertrophic change of prostate the urethra is compressed and urinary outflow obstruction develops. BPH generally involves the central region of the prostate which gradually enlarges. Background: As men’s life expectancy increases, benign prostatic hyperplasia (BPH) is the significant cause of morbidity.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |